NETRI is a company developing innovative technologies for the pharmaceutical industry. Its patented organ-on-a-chip technologies allow the creation of standardized, human and predictive in vitro models. This allows to anticipate the efficacy of an innovative treatment, to accelerate preclinical research phases, and to reposition compounds, while limiting animal testing. The use of human neural circuits coupled with multiple cell types opens the way to more personalized medicine and faster and more relevant diagnostics. Current application areas include neurological disorders, cosmetics and nutrition.


Get involved with Advanced Therapies Congress


To speak

Jessica Robinson
+44 208 164 3086



To sponsor or exhibit

Ashlea Foster
+44 208 164 3032